Breathe Well Live Well
|
Author Martina Chukwuma-Ezike Shares Practical Guide on Understanding and …
PR Web (press release) Years ago, asthma was a debilitating condition which, in many cases, seriously limited what a person could do. As a result of greater knowledge about asthma and its treatment options, the ability to manage this disease has vastly improved over the years. |
View full post on asthma – Google News
Philly.com (blog) |
Mylan shares jump after FDA lays out guidelines for asthma generic
MarketWatch (blog) Shares of Mylan Inc. jumped nearly 5% in mid-afternoon trades on Tuesday after it became clear the U.S. Food and Drug Administration's guidelines on generic forms of GlaxoSmithKline's asthma medication Advair would work in favor of Mylan, considered a … FDA issues generic guidance on GSK's top-selling asthma drug, Advair GlaxoSmithKline Shares Fall After Advair Setback GSK shares hit as Advair generic threat grows in US |
View full post on asthma – Google News
|
Array Shares Climb After Asthma Drug Shows Positive Phase 2 Results
Xconomy Array hopes ARRY-502 can become the next successful oral treatment for asthma, CEO Ron Squarer said during a conference call about the results. The market is substantial, and it has been 15 years since the FDA last approved an oral non-steroidal drug … |
View full post on asthma – Google News
|
Shares jump as Array BioPharma reports positive results for asthma drug
The Pharma Letter US biotech firm Array BioPharma (Nasdaq: ARRY) saw its shares jump as it announced that its drug candidate for mild to moderate persistent allergic asthma, ARRY-502, an oral CRTh2 antagonist, met all primary and secondary endpoints. The company said … |
View full post on asthma – Google News
|
MediciNova shares plunge as asthma drug fails in Ph IIb trial
The Pharma Letter MediciNova intends to design pivotal trial(s) that will include technological and operational improvements and further controls for medications that are not typically used in the treatment of acute exacerbations of asthma and were over-represented in … |
View full post on asthma – Google News
|
MediciNova shares crash after lead asthma drug fails IIb trial
FierceBiotech MediciNova's ($MNOV) shares crashed after the San Diego-based biotech said its Phase IIb study of an acute asthma drug failed to hit the primary endpoint. And while the CEO tried to put the data in context, offering reasons for optimism for a planned … MediciNova asthma drug fails trial; shares crash MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma … |
View full post on asthma – Google News
|
MediciNova asthma drug fails trial; shares crash
Reuters (Reuters) – Biopharmaceutical company MediciNova Inc said its experimental asthma drug failed to meet the main goal of a second mid-stage trial, sending its shares down as much as 51 percent in extended trade. MediciNova, which is testing MN-221 as a … MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma … MediciNova (MNOV) Says Results of Phase 2B Trial of MN-221 Didn't Meet Primary … |
View full post on asthma – Google News
|
SkyePharma's Asthma Treatment Faces European Approval Delay; Shares Fall
RTT News PK: News ) plunged on the London Stock Exchange in Tuesday morning trade, after the British drug delivery specialist reported a delay in review of the European Marketing Authorisation Application or MAA for its asthma therapy Flutiform due to lack of … SkyePharma lung drug faces European approval delay |
View full post on asthma – Google News
|
Becks shares cigar with wife Posh in California sunshine
Times of India Becks, an asthma sufferer, and Posh took turns to puff on the cigar while sunbathing on the roof deck of a beach house in Santa Monica, reports the Daily … |
View full post on asthma – Google News
|
Becks shares cigar with wife Posh in California sunshine
Sify Becks, an asthma sufferer, and Posh took turns to puff on the cigar while sunbathing on the roof deck of a beach house in Santa Monica, reports the Daily … |
View full post on asthma – Google News